{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:09:18Z","timestamp":1794445758866,"version":"4.9.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1053\/j.semnuclmed.2022.01.003","type":"journal-article","created":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T22:28:41Z","timestamp":1646605721000},"page":"611-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["A Role of PET\/MR in Breast Cancer?"],"prefix":"10.1053","volume":"52","author":[{"given":"Nils Martin","family":"Bruckmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janna","family":"Morawitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5106-3584","authenticated-orcid":false,"given":"Wolfgang P.","family":"Fendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Ruckh\u00e4berle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Kathrin","family":"Bittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik L.","family":"Giesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Antoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lale","family":"Umutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8224-3433","authenticated-orcid":false,"given":"Julian","family":"Kirchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0001","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0002","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1055\/a-0646-4630","article-title":"Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF registry number 032\/045OL, December 2017) - Part 2 with recommendations for the therapy of primary, recurrent and advanced Br","volume":"78","author":"Wockel","year":"2018","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0003","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40134-013-0016-x","article-title":"PET\/CT in oncology: current status and perspectives","volume":"1","author":"Czernin","year":"2013","journal-title":"Curr Radiol Rep"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13139-016-0393-1","article-title":"PET\/MRI: technical challenges and recent advances","volume":"50","author":"Jung","year":"2016","journal-title":"Nucl Med Mol Imaging (2010)."},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejrad.2013.11.002","article-title":"Comparison of whole-body PET\/CT and PET\/MRI in breast cancer patients: Lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues","volume":"83","author":"Pace","year":"2014","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0006","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/tbj.12569","article-title":"Standardized uptake values from PET\/MRI in metastatic breast cancer: an organ-based comparison with PET\/CT","volume":"22","author":"Pujara","year":"2016","journal-title":"Breast J"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0007","doi-asserted-by":"crossref","DOI":"10.1148\/rycan.2021200091","article-title":"Measuring glucose uptake in primary invasive breast cancer using simultaneous time-of-flight breast PET\/MRI: a method comparison study with prone PET\/CT","volume":"3","author":"Fowler","year":"2021","journal-title":"Radiol Imaging cancer"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0008","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2214\/AJR.15.14968","article-title":"Current status of hybrid PET\/MRI in oncologic imaging","volume":"206","author":"Rosenkrantz","year":"2016","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0009","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1158\/1078-0432.CCR-13-2810","article-title":"Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility study","volume":"20","author":"Pinker","year":"2014","journal-title":"Clin cancer Res an Off J Am Assoc Cancer Res"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0010","doi-asserted-by":"crossref","first-page":"A26","DOI":"10.1016\/j.ejrad.2017.05.006","article-title":"PET\/MRI of the breast","volume":"94","author":"Plecha","year":"2017","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0011","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/jmri.26298","article-title":"Melsaether AN. PET\/MRI in Breast Cancer","volume":"49","author":"Pujara","year":"2019","journal-title":"J Magn Reson Imaging"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0012","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00259-019-04452-y","article-title":"PET\/MRI versus PET\/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations","volume":"47","author":"Mayerhoefer","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0013","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clinimag.2020.06.002","article-title":"PET\/MRI in breast cancer patients: added value, barriers to implementation, and solutions","volume":"68","author":"Dodelzon","year":"2020","journal-title":"Clin Imaging"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0014","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/physrev.00015.2003","article-title":"Brown adipose tissue: function and physiological significance","volume":"84","author":"Cannon","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0015","first-page":"1789","article-title":"Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET","volume":"44","author":"Yeung","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0016","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1118\/1.4959546","article-title":"Integrated PET\/MR breast cancer imaging: attenuation correction and implementation of a 16-channel RF coil","volume":"43","author":"Oehmigen","year":"2016","journal-title":"Med Phys"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0017","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/a-0828-8654","article-title":"Whole-body [18F]-FDG-PET\/MRI for oncology: a consensus recommendation","volume":"191","author":"Umutlu","year":"2019","journal-title":"Rofo"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0018","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1007\/s00259-018-4102-4","article-title":"Local and whole-body staging in patients with primary breast cancer: a comparison of one-step to two-step staging utilizing 18F-FDG-PET\/MRI","volume":"45","author":"Kirchner","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0019","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1002\/mp.12449","article-title":"MR-based truncation and attenuation correction in integrated PET\/MR hybrid imaging using HUGE with continuous table motion","volume":"44","author":"Lindemann","year":"2017","journal-title":"Med Phys"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0020","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1007\/s00330-015-3807-z","article-title":"Breast MRI: EUSOBI recommendations for women's information","volume":"25","author":"Mann","year":"2015","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0021","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1148\/radiol.2461061298","article-title":"Meta-analysis of MR imaging in the diagnosis of breast lesions","volume":"246","author":"Peters","year":"2008","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160346","article-title":"Diagnostic performance of breast magnetic resonance imaging in non-calcified equivocal breast findings: results from a systematic review and meta-analysis","volume":"11","author":"Bennani-Baiti","year":"2016","journal-title":"PLoS One"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0023","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1148\/radiol.2019182947","article-title":"Breast MRI: state of the art","volume":"292","author":"Mann","year":"2019","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0024","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/S1470-2045(21)00577-5","article-title":"Clinical advances in PET-MRI for breast cancer","volume":"23","author":"Fowler","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0025","first-page":"369","article-title":"Role of fusion of prone FDG-PET and magnetic resonance imaging of the breasts in the evaluation of breast cancer","volume":"16","author":"Moy","year":"2010","journal-title":"Breast J"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0026","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1007\/s00330-015-4054-z","article-title":"Clinical utility of 18F-FDG-PET\/MR for preoperative breast cancer staging","volume":"26","author":"Botsikas","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0027","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ejrad.2009.10.031","article-title":"\u201cOne-stop-shop\u201d staging: should we prefer FDG-PET\/CT or MRI for the detection of bone metastases?","volume":"78","author":"Heusner","year":"2011","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0028","doi-asserted-by":"crossref","DOI":"10.1097\/RLI.0000000000000197","article-title":"Positron emission tomography\/magnetic resonance imaging for local tumor staging in patients with primary breast cancer: a comparison with positron emission tomography\/computed tomography and magnetic resonance imaging","author":"Grueneisen","year":"2015","journal-title":"Invest Radiol."},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0029","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1007\/s00330-016-4685-8","article-title":"MRI fused with prone FDG PET\/CT improves the primary tumour staging of patients with breast cancer","volume":"27","author":"Garcia-Velloso","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0030","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1007\/s00259-015-3099-1","article-title":"Diagnostic accuracy of (18)F-FDG PET\/CT compared with that of contrast-enhanced MRI of the breast at 3 T","volume":"42","author":"Magometschnigg","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0031","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.ejrad.2014.05.021","article-title":"Can 18F-FDG PET improve the evaluation of suspicious breast lesions on MRI?","volume":"83","author":"Bitencourt","year":"2014","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0032","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2214\/AJR.15.14656","article-title":"Contribution of FDG PET\/CT for the optimization of the management of additional lesions detected on local staging breast MRI","volume":"206","author":"Jalaguier-Coudray","year":"2016","journal-title":"AJR Am J Roentgenol."},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0033","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2214\/AJR.16.17766","article-title":"Reliability of (18)F-FDG PET metabolic parameters derived using simultaneous PET\/MRI and correlation with prognostic factors of invasive ductal carcinoma: a feasibility study","volume":"209","author":"Jena","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0034","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11604-017-0707-y","article-title":"Simultaneous whole-body and breast 18F-FDG PET\/MRI examinations in patients with breast cancer: a comparison of apparent diffusion coefficients and maximum standardized uptake values","volume":"36","author":"Sasaki","year":"2018","journal-title":"Jpn J Radiol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0035","first-page":"171","article-title":"Initial experience of integrated PET\/MR mammography in patients with invasive ductal carcinoma","volume":"17","author":"Kong","year":"2014","journal-title":"Hell J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0036","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/RLU.0000000000003488","article-title":"Prospective correlation of prognostic immunohistochemical markers with SUV and ADC derived from dedicated hybrid breast 18F-FDG PET\/MRI in women with newly diagnosed breast cancer","volume":"46","author":"Morawitz","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0037","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1007\/s00259-018-4010-7","article-title":"Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET\/MRI study","volume":"45","author":"Incoronato","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0038","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/bjc.2017.26","article-title":"PET\/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype","volume":"116","author":"Catalano","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0039","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1097\/RLU.0000000000001254","article-title":"Assessment of aggressiveness of breast cancer using simultaneous 18F-FDG-PET and DCE-MRI: preliminary observation","volume":"41","author":"Margolis","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0040","doi-asserted-by":"crossref","first-page":"e4026","DOI":"10.1002\/nbm.4026","article-title":"A multi-parametric PET\/MRI study of breast cancer: evaluation of DCE-MRI pharmacokinetic models and correlation with diffusion and functional parameters","volume":"32","author":"Inglese","year":"2019","journal-title":"NMR Biomed"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0041","first-page":"290","article-title":"Breast cancer-major changes in the American joint committee on cancer eighth edition cancer staging manual","volume":"67","author":"Giuliano","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0042","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/annonc\/mdy192","article-title":"4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4)dagger","volume":"29","author":"Cardoso","year":"2018","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0043","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.annonc.2020.09.010","article-title":"5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)","volume":"31","author":"Cardoso","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0044","first-page":"552","article-title":"NCCN guidelines updates: breast cancer","volume":"17","author":"Telli","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0045","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00259-016-3402-9","article-title":"18F-FDG-PET\/CT for systemic staging of newly diagnosed triple-negative breast cancer","volume":"43","author":"Ulaner","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0046","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1007\/s00259-017-3709-1","article-title":"18F\u2013FDG-PET\/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancer","volume":"44","author":"Ulaner","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0047","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.2967\/jnumed.114.143297","article-title":"Retrospective Analysis of 18F-FDG PET\/CT for Staging Asymptomatic Breast Cancer Patients Younger Than 40 Years","volume":"55","author":"Riedl","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.108975","article-title":"Impact of (18)F-FDG PET\/MR on therapeutic management in high risk primary breast cancer patients - A prospective evaluation of staging algorithms","volume":"128","author":"Kirchner","year":"2020","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0049","first-page":"1","article-title":"Breast cancer: initial workup and staging with FDG PET\/CT","author":"Groheux","year":"2021","journal-title":"Clin Transl imaging."},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0050","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1148\/radiol.13131306","article-title":"Clinical impact of PET\/MR imaging in patients with cancer undergoing same-day PET\/CT: initial experience in 134 patients\u2013a hypothesis-generating exploratory study","volume":"269","author":"Catalano","year":"2013","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0051","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/bjc.2015.112","article-title":"Comparison of CE-FDG-PET\/CT with CE-FDG-PET\/MR in the evaluation of osseous metastases in breast cancer patients","volume":"112","author":"Catalano","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0052","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ejrad.2015.12.010","article-title":"Evaluation of 18F-FDG PET\/MRI, 18F-FDG PET\/CT, MRI, and CT in whole-body staging of recurrent breast cancer","volume":"85","author":"Sawicki","year":"2016","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0053","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1148\/radiol.2016151155","article-title":"Comparison of whole-body 18 F FDG PET\/MR imaging and whole-body 18 F FDG PET\/CT in terms of lesion detection and radiation dose in patients with breast cancer","volume":"281","author":"Melsaether","year":"2016","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0054","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00259-017-3823-0","article-title":"Added value of dedicated axillary hybrid 18F-FDG PET\/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study","volume":"45","author":"van Nijnatten","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0055","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00330-018-5720-8","article-title":"What is the diagnostic performance of 18-FDG-PET\/MR compared to PET\/CT for the N- and M- staging of breast cancer?","volume":"29","author":"Botsikas","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0056","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/MNM.0000000000001254","article-title":"Diagnostic performance of PET\/computed tomography versus PET\/MRI and diffusion-weighted imaging in the N- and M-staging of breast cancer patients","volume":"41","author":"de Mooij","year":"2020","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0057","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1007\/s00259-017-3745-x","article-title":"Hybrid (18)F-FDG PET\/MRI might improve locoregional staging of breast cancer patients prior to neoadjuvant chemotherapy","volume":"44","author":"Goorts","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0058","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.ejrad.2014.09.008","article-title":"Simultaneous whole-body 18F-FDG PET-MRI in primary staging of breast cancer: a pilot study","volume":"83","author":"Taneja","year":"2014","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0059","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1007\/s00259-020-04801-2","article-title":"Prospective evaluation of whole-body MRI and (18)F-FDG PET\/MRI in N and M staging of primary breast cancer patients","volume":"47","author":"Bruckmann","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0060","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00259-021-05502-0","article-title":"Comparison of nodal staging between CT, MRI, and [(18)F]-FDG PET\/MRI in patients with newly diagnosed breast cancer","volume":"49","author":"Morawitz","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0061","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2967\/jnumed.121.262009","article-title":"Determining the axillary nodal status with four current imaging modalities including (18)F-FDG PET\/MRI in newly diagnosed breast cancer: a comparative study using histopathology as reference standard","volume":"62","author":"Morawitz","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0062","doi-asserted-by":"crossref","first-page":"8714","DOI":"10.1007\/s00330-021-07956-0","article-title":"Prospective comparison of the diagnostic accuracy of 18F-FDG PET\/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients","volume":"31","author":"Bruckmann","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0063","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2017.4012","article-title":"Staging performance of whole-body DWI, PET\/CT and PET\/MRI in invasive ductal carcinoma of the breast","author":"Catalano","year":"2017","journal-title":"Int J Oncol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0064","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/RLU.0000000000003502","article-title":"Impact of 18F-FDG PET, PET\/CT, and PET\/MRI on staging and management as an initial staging modality in breast cancer: a systematic review and meta-analysis","volume":"46","author":"Han","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0065","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.21037\/apm-20-2555","article-title":"Diagnostic role of 18F-FDG PET\/MRI in the TNM staging of breast cancer: a systematic review and meta-analysis","volume":"10","author":"Lu","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0066","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejrad.2018.09.003","article-title":"Staging\/restaging performance of F18-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in breast cancer: a review and meta-analysis","volume":"107","author":"Lin","year":"2018","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0067","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejrad.2017.04.013","article-title":"Association of pharmacokinetic and metabolic parameters derived using simultaneous PET\/MRI: initial findings and impact on response evaluation in breast cancer","volume":"92","author":"Jena","year":"2017","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0068","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.3390\/cancers13143521","article-title":"Assessment and prediction of response to neoadjuvant chemotherapy in breast cancer: a comparison of imaging modalities and future perspectives","volume":"13","author":"Romeo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0069","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/RLU.0000000000001684","article-title":"Multiparametric evaluation of treatment response to neoadjuvant chemotherapy in breast cancer using integrated PET\/MR","volume":"42","author":"Wang","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0070","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-017-3849-3","article-title":"Integrated (18)F-FDG PET\/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapy","volume":"45","author":"Cho","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0071","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.3390\/cancers13194946","article-title":"FAP and FAPI-PET\/CT in malignant and non-malignant diseases: a perfect symbiosis?","volume":"13","author":"Dendl","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0072","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"(68)Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0073","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00259-021-05442-9","article-title":"(68)Ga-FAPI-04 vs. (18)F-FDG in a longitudinal preclinical PET imaging of metastatic breast cancer","volume":"49","author":"Ding","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.01.003_bib0074","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1148\/radiol.2021204677","article-title":"Simultaneous FAPI PET\/MRI targeting the fibroblast-activation protein for breast cancer","volume":"302","author":"Backhaus","year":"2022","journal-title":"Radiology"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299822000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299822000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:39:36Z","timestamp":1757543976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299822000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0001299822000034"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2022.01.003","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Role of PET\/MR in Breast Cancer?","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2022.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}